Summary
- Main use
- Correction of fluid and electrolyte deficiencies and nutritional deficiencies (amino acids and calories)
- Who receives it
- Adults
- Adult administration
- Administer via a peripheral vein. The infusion rate should be determined by considering the total volume to be administered, the characteristics of the final admixture, the daily dose, and the infusion duration. Usually, the infusion rate is gradually increased over the first 30 minutes~1 hour until the appropriate rate is reached. Administration over 12~24 hours is preferred. Do not administer for more than 7 days. The maximum infusion rate should not exceed 2.5mL/kg/hour. (Equivalent to amino acids 0.08 g/kg/hour, glucose 0.16 g/kg/hour, and fat 0.1g/kg/hour) The dose should be determined according to the patient's condition, caloric expenditure, and metabolic requirements. - Determine the dose according to the patient's nutritional status and degree of catabolism, but do not exceed 40kcal/kg daily. Exceptions may be made in special cases, such as patients with burns. - Maximum daily dose: 40mL per kg of body weight (equivalent to amino acids 1.28g/kg, glucose 2.56g/kg, and fat 1.6g/kg)
Ingredients
- Glucose Monohydrate70.4g
- Monobasic Sodium Phosphate Dihydrate0.936g
- Zinc Acetate Hydrate5.3mg
- L-Isoleucine1.872g
- L-Leucine2.504g
- L-Lysine Hydrochloride2.272g
- L-Methionine1.568g
- L-Phenylalanine2.808g
- L-Threonine1.456g
- L-Tryptophan0.456g
- L-Valine2.08g
- L-Arginine2.16g
- L-Histidine Hydrochloride Monohydrate1.352g
- L-Alanine3.88g
- L-Aspartic Acid1.2g
- L-Glutamic Acid2.8g
- Glycine1.32g
- L-Proline2.72g
- L-Serine2.4g
- Sodium Hydroxide0.64g
- Sodium Chloride0.8648g
- Sodium Acetate Hydrate0.4352g
- Potassium Acetate2.3544g
- Magnesium Acetate Tetrahydrate0.5152g
- Calcium Chloride Hydrate0.3528g
- Soybean Oil20g
- Triglycerides Medium-Chain20g
- Manufacturer
- JW Pharmaceutical Co., Ltd.
Efficacy & effects
Correction of fluid and electrolyte deficiencies and nutritional deficiencies (amino acids and calories)
View approved original textHide original text
This medication is used to improve nutritional status by supplying fluids, electrolytes, amino acids, and calories to patients who have difficulty with oral or gastrointestinal nutrition.
How it is given
Adult administration
Administer via a peripheral vein. The infusion rate should be determined by considering the total volume to be administered, the characteristics of the final admixture, the daily dose, and the infusion duration. Usually, the infusion rate is gradually increased over the first 30 minutes~1 hour until the appropriate rate is reached. Administration over 12~24 hours is preferred. Do not administer for more than 7 days. The maximum infusion rate should not exceed 2.5mL/kg/hour. (Equivalent to amino acids 0.08 g/kg/hour, glucose 0.16 g/kg/hour, and fat 0.1g/kg/hour) The dose should be determined according to the patient's condition, caloric expenditure, and metabolic requirements. - Determine the dose according to the patient's nutritional status and degree of catabolism, but do not exceed 40kcal/kg daily. Exceptions may be made in special cases, such as patients with burns. - Maximum daily dose: 40mL per kg of body weight (equivalent to amino acids 1.28g/kg, glucose 2.56g/kg, and fat 1.6g/kg)
Precautions
This medication should only be used according to a physician's instructions. If severe allergic reactions such as anaphylaxis occur, administration should be stopped immediately. When used with the drug Ceftriaxone, precipitates may form, so the same infusion device should not be used simultaneously. Particular caution is advised when administering to premature or low-birth-weight infants, as lipid metabolism may be problematic. Patients with a history of prematurity, neonates, egg or soybean oil allergies, severe renal failure, or liver disease should not use this medication. Patients with specific diseases such as renal failure, diabetes, or liver dysfunction must use this medication cautiously and have their blood lipid levels frequently monitored. Excessive dosing or rapid infusion can lead to adverse effects, so caution is required. If symptoms such as fever, chills, headaches, vomiting, or difficulty breathing occur during administration, stop the administration immediately. Regular liver function and blood tests should be performed in patients using the medication for an extended period. Caution must be exercised when administering this medication concurrently with blood, as blood coagulation may occur. Pregnant or breastfeeding women should consult with a physician to determine whether to use this medication. If blood tests are to be conducted within a few hours after administration, the drug components may affect the test results, so it is recommended to have the tests done at an appropriate time. In cases of overdose, symptoms such as acidosis, hypervolemia, hyperglycemia, dehydration, or pulmonary edema may arise, necessitating immediate notification to medical personnel and appropriate treatment. Do not use the medication if it is damaged or deteriorated, and use it quickly after opening, disposing of any remaining medication afterwards. Store in a sealed container away from air or light. It is best to keep it in a cool place between 15 and 25 degrees Celsius, and do not freeze.
Side effects
Anaphylactic reactions (fever, chills, rash, difficulty breathing), increased body temperature, sweating, trembling, headache, vomiting, difficulty breathing, increased liver function test values, hepatomegaly, jaundice, thrombophlebitis, hyperlipemia syndrome (hyperlipidemia, fever, fat deposition, hepatomegaly, splenomegaly, anemia, leukopenia, thrombocytopenia, blood coagulation abnormalities, coma), flushing, chills, loss of appetite, nausea, respiratory distress, bone pain, chest pain, back pain, increased blood pressure, decreased blood pressure, hypersensitivity symptoms, skin erythema, cyanosis, intra-tissue fat accumulation, pathological liver function abnormalities, blood coagulation factor degeneration or reduction, abnormal blood symptoms, abdominal pain, fatigue, phlebitis, thrombophlebitis, vomiting, nausea, fever, headache, abdominal pain, fatigue, bleeding
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a sealed container to avoid exposure to air or light. It is advisable to keep it in a cool place between 15 and 25 degrees Celsius.
Appearance and packaging
Appearance
This drug consists of an internal bag and external packaging made of polypropylene, divided into three compartments, with an oxygen absorber in between. Each internal bag compartment contains dextrose and
Package unit
250 mL/bag, 375 mL/bag, 1250 mL/bag, 1875 mL/bag
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.